These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17851232)

  • 1. Gene polymorphisms and serum alpha-2-Heremans-Schmid levels in Italian haemodialysis patients.
    Cozzolino M; Biondi ML; Galassi A; Gallieni M; d'Eril GV; Brancaccio D
    Am J Nephrol; 2007; 27(6):639-42. PubMed ID: 17851232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of AHSG gene polymorphisms and aortic stiffness in peritoneal dialysis patients.
    Jung JY; Hwang YH; Lee H; Ro H; Lee H; Chung W; Chae DW; Joo KW; Ahn C; Oh KH
    Am J Nephrol; 2010; 31(6):510-7. PubMed ID: 20453496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study.
    Fisher E; Stefan N; Saar K; Drogan D; Schulze MB; Fritsche A; Joost HG; Häring HU; Hubner N; Boeing H; Weikert C
    Circ Cardiovasc Genet; 2009 Dec; 2(6):607-13. PubMed ID: 20031641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is fetuin-A/alpha2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
    Axelsson J; Wang X; Ketteler M; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Nordfors L; Stenvinkel P
    Am J Nephrol; 2008; 28(4):669-76. PubMed ID: 18337634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
    Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
    Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of alpha2-Heremans-Schmid glycoprotein polymorphism with late-onset Alzheimer's disease in Italians.
    Geroldi D; Minoretti P; Bianchi M; Di Vito C; Reino M; Bertona M; Emanuele E
    Neurosci Lett; 2005 Oct; 386(3):176-8. PubMed ID: 16002217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.
    Ketteler M; Bongartz P; Westenfeld R; Wildberger JE; Mahnken AH; Böhm R; Metzger T; Wanner C; Jahnen-Dechent W; Floege J
    Lancet; 2003 Mar; 361(9360):827-33. PubMed ID: 12642050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of alpha2-Heremans-Schmid glycoprotein polymorphisms with subclinical atherosclerosis.
    Lehtinen AB; Burdon KP; Lewis JP; Langefeld CD; Ziegler JT; Rich SS; Register TC; Carr JJ; Freedman BI; Bowden DW
    J Clin Endocrinol Metab; 2007 Jan; 92(1):345-52. PubMed ID: 17062776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.
    Stenvinkel P; Wang K; Qureshi AR; Axelsson J; Pecoits-Filho R; Gao P; Barany P; Lindholm B; Jogestrand T; Heimbürger O; Holmes C; Schalling M; Nordfors L
    Kidney Int; 2005 Jun; 67(6):2383-92. PubMed ID: 15882283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetuin-A serum levels are not correlated to kidney function in long-lived subjects.
    Bellia C; Tomaiuolo R; Caruso A; Sasso BL; Zarrilli F; Carru C; Deiana M; Zinellu A; Pinna S; Castaldo G; Deiana L; Ciaccio M
    Clin Biochem; 2012 Jun; 45(9):637-40. PubMed ID: 22425942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients.
    Brancaccio D; Biondi ML; Gallieni M; Turri O; Galassi A; Cecchini F; Russo D; Andreucci V; Cozzolino M
    Am J Nephrol; 2005; 25(6):548-52. PubMed ID: 16210837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
    Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
    Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S; Lindholm B; Axelsson J; Qureshi RA; Barany P; Heimbürger O; Gustafsson JA; Stenvinkel P; Nordfors L
    Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AHSG gene variation is not associated with regional body fat distribution--a magnetic resonance study.
    Müssig K; Staiger H; Machicao F; Machann J; Hennige AM; Schick F; Claussen CD; Fritsche A; Häring HU; Stefan N
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):432-7. PubMed ID: 19358088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased aortic wall stiffness associated with low circulating fetuin A and high C-reactive protein in predialysis patients.
    Porazko T; Kuźniar J; Kusztal M; Kuźniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephron Clin Pract; 2009; 113(2):c81-7. PubMed ID: 19602903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetuin-A gene polymorphism in patients with calcium oxalate stone disease.
    Aksoy H; Aksoy Y; Ozturk N; Aydin HR; Yildirim AK; Akçay F
    Urology; 2010 Apr; 75(4):928-32. PubMed ID: 19931899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation.
    David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT
    Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.